世界のプレガバリン市場2022年-2028年:剤形別(カプセル、溶液、錠剤、徐放)、用途別、薬効別、エンドユーザー別、流通チャネル別、地域別

【英語タイトル】Global Pregabalin Market Size study, By Dosage Forms (Oral Capsule, Oral Solution, Oral Tablet, Extended Release), By Application (Epilepsy, Neuropathic Pain, Anxiety Disorder, Others), By Drug Class (Fibromyalgia Agents, Anticonvulsants, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028

Bizwit Research & Consultingが出版した調査資料(BZW22JN225)・商品コード:BZW22JN225
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2022年5月31日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥663,300見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥837,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Bizwit Research社は、2021年におよそXX百万ドルであった世界のプレガバリン市場規模が、2022年から2028年の間にXX%以上成長すると予測しています。本調査レポートでは、プレガバリンの世界市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、用途別(てんかん、神経障害性疼痛、不安障害、その他)分析、薬効別(線維筋痛症治療薬、抗けいれん薬、その他)分析、剤形別(カプセル、溶液、錠剤、徐放)分析、エンドユーザー別(病院、専門クリニック、在宅医療)分析、地域別分析、競争分析、調査プロセスなどを掲載しています。本調査レポートでは、Pfizer Inc. (US)、GlaxoSmithKline plc (UK)、Novartis AG (Switzerland)、Mylan N.V. (US)、Teva Pharmaceutical Industries Ltd. (Israel)、Sanofi (France)、F. Hoffmann-La Roche Ltd. (Switzerland)、Aurobindo Pharma (India)、Lupin (India)、Zydus Cadila (India)などの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界のプレガバリン市場規模:用途別(てんかん、神経障害性疼痛、不安障害、その他)
・世界のプレガバリン市場規模:薬効別(線維筋痛症治療薬、抗けいれん薬、その他)
・世界のプレガバリン市場規模:剤形別(カプセル、溶液、錠剤、徐放)
・世界のプレガバリン市場規模:エンドユーザー別(病院、専門クリニック、在宅医療)
・世界のプレガバリン市場規模:地域別
・競争分析
・調査プロセス
【レポートの概要】

Global Pregabalin Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028.

Pregabalin also called an anticonvulsant is an anti-epileptic medication, used for treatment of neurological conditions such as epilepsy and anxiety. It is also effective in treatment of nerve pain, such as burning, shooting, or stabbing pain. Pregabalin comes in capsules and oral solution. Rising prevalence of epilepsy worldwide and increasing application of Lyrica (Pregabalin) as well as growing healthcare expenditure are driving the growth for Pregabalin Market. For instance, according to World Health Organization (WHO) – as of 2021, around 5 million people are diagnosed with epilepsy every year.
This disease is more prevalent in Low- & Middle-income countries. In low-income countries 139 per 100 000 people are affected by epilepsy. Whereas, in high income countries 49 per 100 000 people diagnosed with epilepsy each year . Moreover, in August 20219, The United States Food and Drug Administration granted approvals to nine pharma companies for development of first generic version of Lyrica (pregabalin). These nine companies were Alembic Pharmaceuticals, Alkem Laboratories, Amneal Pharmaceuticals, Dr Reddy’s Laboratories, InvaGen Pharmaceuticals, MSN Laboratories, Rising Pharmaceuticals, Sciegen Pharmaceuticals, and Teva Pharmaceuticals. Also, growing number of generic drug manufacturers and rising healthcare sector in emerging markets are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, side effects associated with Pregabalin impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Pregabalin Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to presence of leading market players and favorable government initiatives towards generic drug manufacturing in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as increasing prevalence of neurological disorders and growing healthcare infrastructure in the region, would create lucrative growth prospects for the Pregabalin Market across the Asia Pacific region.

Major market players included in this report are:
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
F. Hoffmann-La Roche Ltd. (Switzerland)
Aurobindo Pharma (India)
Lupin (India)
Zydus Cadila (India)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Dosage Forms
Oral Capsule
Oral Solution
Oral Tablet
Extended Release

By Application
Epilepsy
Neuropathic Pain
Anxiety Disorder
Others

By Drug Class
Fibromyalgia Agents
Anticonvulsants
Others

By End-Users
Hospitals
Specialty Clinics
Homecare
Others

By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Pregabalin Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Pregabalin Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Pregabalin Market, by Application, 2020-2028 (USD Million)
1.2.3. Global Pregabalin Market, by Drug Class, 2020-2028 (USD Million)
1.2.4. Global Pregabalin Market, by Dosage Forms, 2020-2028 (USD Million)
1.2.5. Global Pregabalin Market, by End-Users, 2020-2028 (USD Million)
1.2.6. Global Pregabalin Market, by Distribution Channel, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pregabalin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pregabalin Market Dynamics
3.1. Pregabalin Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of epilepsy worldwide.
3.1.1.2. Increasing application of Lyrica (Pregabalin).
3.1.1.3. Growing healthcare expenditure.
3.1.2. Market Challenges
3.1.2.1. Side effects associated with Pregabalin.
3.1.3. Market Opportunities
3.1.3.1. Growing number of generic drug manufacturers.
3.1.3.2. Rising healthcare sector in emerging Markets.
Chapter 4. Global Pregabalin Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Pregabalin Market, by Application
6.1. Market Snapshot
6.2. Global Pregabalin Market by Application, Performance – Potential Analysis
6.3. Global Pregabalin Market Estimates & Forecasts by Application 2018-2028 (USD Million)
6.4. Pregabalin Market, Sub Segment Analysis
6.4.1. Epilepsy
6.4.2. Neuropathic Pain
6.4.3. Anxiety Disorder
6.4.4. Others
Chapter 7. Global Pregabalin Market, by Drug Class
7.1. Market Snapshot
7.2. Global Pregabalin Market by Drug Class, Performance – Potential Analysis
7.3. Global Pregabalin Market Estimates & Forecasts by Drug Class 2018-2028 (USD Million)
7.4. Pregabalin Market, Sub Segment Analysis
7.4.1. Fibromyalgia Agents
7.4.2. Anticonvulsants
7.4.3. Others
Chapter 8. Global Pregabalin Market, by Dosage Forms
8.1. Market Snapshot
8.2. Global Pregabalin Market by Dosage Forms, Performance – Potential Analysis
8.3. Global Pregabalin Market Estimates & Forecasts by Dosage Forms 2018-2028 (USD Million)
8.4. Pregabalin Market, Sub Segment Analysis
8.4.1. Oral Capsule
8.4.2. Oral Solution
8.4.3. Oral Tablet
8.4.4. Extended Release
Chapter 9. Global Pregabalin Market, by End-Users
9.1. Market Snapshot
9.2. Global Pregabalin Market by End-Users, Performance – Potential Analysis
9.3. Global Pregabalin Market Estimates & Forecasts by End-Users 2018-2028 (USD Million)
9.4. Pregabalin Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Specialty Clinics
9.4.3. Homecare
9.4.4. Others
Chapter 10. Global Pregabalin Market, by Distribution Channel
10.1. Market Snapshot
10.2. Global Pregabalin Market by Distribution Channel, Performance – Potential Analysis
10.3. Global Pregabalin Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)
10.4. Pregabalin Market, Sub Segment Analysis
10.4.1. Hospital Pharmacy
10.4.2. Retail Pharmacy
10.4.3. Online Pharmacy
10.4.4. Others

Chapter 11. Global Pregabalin Market, Regional Analysis
11.1. Pregabalin Market, Regional Market Snapshot
11.2. North America Pregabalin Market
11.2.1. U.S. Pregabalin Market
11.2.1.1. Application estimates & forecasts, 2018-2028
11.2.1.2. Drug Class estimates & forecasts, 2018-2028
11.2.1.3. Dosage Forms estimates & forecasts, 2018-2028
11.2.1.4. End-Users estimates & forecasts, 2018-2028
11.2.1.5. Distribution Channel estimates & forecasts, 2018-2028
11.2.2. Canada Pregabalin Market
11.3. Europe Pregabalin Market Snapshot
11.3.1. U.K. Pregabalin Market
11.3.2. Germany Pregabalin Market
11.3.3. France Pregabalin Market
11.3.4. Spain Pregabalin Market
11.3.5. Italy Pregabalin Market
11.3.6. Rest of Europe Pregabalin Market
11.4. Asia-Pacific Pregabalin Market Snapshot
11.4.1. China Pregabalin Market
11.4.2. India Pregabalin Market
11.4.3. Japan Pregabalin Market
11.4.4. Australia Pregabalin Market
11.4.5. South Korea Pregabalin Market
11.4.6. Rest of Asia Pacific Pregabalin Market
11.5. Latin America Pregabalin Market Snapshot
11.5.1. Brazil Pregabalin Market
11.5.2. Mexico Pregabalin Market
11.6. Rest of The World Pregabalin Market

Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Pfizer Inc. (US)
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Product Summary
12.2.1.5. Recent Developments
12.2.2. GlaxoSmithKline plc (UK)
12.2.3. Novartis AG (Switzerland)
12.2.4. Mylan N.V. (US)
12.2.5. Teva Pharmaceutical Industries Ltd. (Israel)
12.2.6. Sanofi (France)
12.2.7. F. Hoffmann-La Roche Ltd. (Switzerland)
12.2.8. Aurobindo Pharma (India)
12.2.9. Lupin (India)
12.2.10. Zydus Cadila (India)

Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption

List of Tables
TABLE 1. Global Pregabalin Market, report scope
TABLE 2. Global Pregabalin Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Pregabalin Market estimates & forecasts by Application 2018-2028 (USD Million)
TABLE 4. Global Pregabalin Market estimates & forecasts by Drug Class 2018-2028 (USD Million)
TABLE 5. Global Pregabalin Market estimates & forecasts by Dosage Forms 2018-2028 (USD Million)
TABLE 6. Global Pregabalin Market estimates & forecasts by End-Users 2018-2028 (USD Million)
TABLE 7. Global Pregabalin Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)
TABLE 8. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 18. U.S. Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 19. U.S. Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 20. U.S. Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. Canada Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 22. Canada Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 23. Canada Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. UK Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 25. UK Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 26. UK Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. Germany Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 28. Germany Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 29. Germany Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. RoE Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 31. RoE Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 32. RoE Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. China Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 34. China Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 35. China Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. India Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 37. India Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 38. India Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. Japan Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 40. Japan Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 41. Japan Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. RoAPAC Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 43. RoAPAC Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 44. RoAPAC Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Brazil Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 46. Brazil Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 47. Brazil Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. Mexico Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 49. Mexico Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 50. Mexico Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. RoLA Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 52. RoLA Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 53. RoLA Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. Row Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 55. Row Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 56. Row Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 57. List of secondary sources, used in the study of global Pregabalin Market
TABLE 58. List of primary sources, used in the study of global Pregabalin Market
TABLE 59. Years considered for the study
TABLE 60. Exchange rates considered

List of figures
FIG 1. Global Pregabalin Market, research methodology
FIG 2. Global Pregabalin Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Pregabalin Market, key trends 2021
FIG 5. Global Pregabalin Market, growth prospects 2022-2028
FIG 6. Global Pregabalin Market, porters 5 force model
FIG 7. Global Pregabalin Market, pest analysis
FIG 8. Global Pregabalin Market, value chain analysis
FIG 9. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
FIG 10. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
FIG 11. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
FIG 12. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
FIG 13. Global Pregabalin Market by segment, 2018 & 2028 (USD Million)
FIG 14. Global Pregabalin Market, regional snapshot 2018 & 2028
FIG 15. North America Pregabalin Market 2018 & 2028 (USD Million)
FIG 16. Europe Pregabalin Market 2018 & 2028 (USD Million)
FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
FIG 18. Latin America Pregabalin Market 2018 & 2028 (USD Million)
FIG 19. Global Pregabalin Market, company Market share analysis (2021)













★調査レポート[世界のプレガバリン市場2022年-2028年:剤形別(カプセル、溶液、錠剤、徐放)、用途別、薬効別、エンドユーザー別、流通チャネル別、地域別] (コード:BZW22JN225)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のプレガバリン市場2022年-2028年:剤形別(カプセル、溶液、錠剤、徐放)、用途別、薬効別、エンドユーザー別、流通チャネル別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆